{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:34:47Z","timestamp":1791182087223,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T00:00:00Z","timestamp":1155254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,12,21]]},"DOI":"10.1007\/s10067-006-0369-0","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T09:08:45Z","timestamp":1155200925000},"page":"242-243","source":"Crossref","is-referenced-by-count":38,"title":["Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis"],"prefix":"10.1007","volume":"26","author":[{"given":"M.","family":"Laroche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mazi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,11]]},"reference":[{"issue":"5","key":"369_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","volume":"122","author":"P Valent","year":"2003","unstructured":"Valent P et al (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122(5):695\u2013717","journal-title":"Br J Haematol"},{"issue":"7","key":"369_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0145-2126(01)00046-7","volume":"25","author":"DD Metcalfe","year":"2001","unstructured":"Metcalfe DD, Akin C (2001) Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res 25(7):577\u2013582","journal-title":"Leuk Res"},{"issue":"1","key":"369_CR3","first-page":"57","volume":"59","author":"B Grardel","year":"1992","unstructured":"Grardel B, Hardouin P (1992) Mastocytosis and bone manifestations. Results of the survey of the bone and phosphorus\u2013calcium metabolism section of the French Society of Rheumatology. Rev Rhum Mal Osteoartic 59(1):57\u201363","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"Suppl 1","key":"369_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01621891","volume":"3","author":"A Chines","year":"1993","unstructured":"Chines A et al (1993) Systemic mastocytosis and osteoporosis. Osteoporos Int 3(Suppl 1):147","journal-title":"Osteoporos Int"},{"key":"369_CR5","first-page":"281","volume":"279","author":"C Gennes De","year":"1992","unstructured":"De Gennes C, Kuntz D, de Vernejoul MC (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop (279):281\u2013291","journal-title":"Clin Orthop"},{"issue":"13","key":"369_CR6","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","volume":"102","author":"HC Kluin-Nelemans","year":"2003","unstructured":"Kluin-Nelemans HC et al (2003) Cladribine therapy for systemic mastocytosis. Blood 102(13):4270\u20134276","journal-title":"Blood"},{"issue":"9383","key":"369_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(03)14115-3","volume":"362","author":"A Pardanani","year":"2003","unstructured":"Pardanani A et al (2003) Imatinib for systemic mast-cell disease. Lancet 362(9383):535\u2013536","journal-title":"Lancet"},{"issue":"5","key":"369_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.patbio.2004.04.012","volume":"52","author":"J Simon","year":"2004","unstructured":"Simon J et al (2004) Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature. Pathol Biol (Paris) 52(5):294\u2013299","journal-title":"Pathol Biol (Paris)"},{"issue":"2","key":"369_CR9","first-page":"64","volume":"27","author":"V Brunel","year":"1998","unstructured":"Brunel V et al (1998) Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis. Presse Med 27(2):64","journal-title":"Presse Med"},{"issue":"1","key":"369_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","volume":"72","author":"R Weide","year":"1996","unstructured":"Weide R et al (1996) Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Ann Hematol 72(1):41\u201343","journal-title":"Ann Hematol"},{"issue":"3","key":"369_CR11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/rheumatology\/36.3.393","volume":"36","author":"A Marshall","year":"1997","unstructured":"Marshall A, Kavanagh RT, Crisp AJ (1997) The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 36(3):393\u2013396","journal-title":"Br J Rheumatol"},{"issue":"4","key":"369_CR12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1359\/jbmr.2002.17.4.567","volume":"17","author":"C Brumsen","year":"2002","unstructured":"Brumsen C, Hamdy NA, Papapoulos SE (2002) Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res 17(4):567\u2013569","journal-title":"J Bone Miner Res"},{"issue":"9","key":"369_CR13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","volume":"35","author":"T Lehmann","year":"1996","unstructured":"Lehmann T et al (1996) Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. Br J Rheumatol 35(9):898\u2013900","journal-title":"Br J Rheumatol"},{"issue":"Suppl 2","key":"369_CR14","first-page":"S190","volume":"11","author":"HW Minne","year":"2000","unstructured":"Minne HW et al (2000) Pamidronate is effective in the treatment of osteoporosis in men due to systemic mastocytosis: a prospective, controlled study. Osteoporos Int 11(Suppl 2):S190 (abstract)","journal-title":"Osteoporos Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0369-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0369-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:01Z","timestamp":1559105461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0369-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,11]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12,21]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0369-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,11]]}}}